Go Pro
→ The cat is out the bag (From Porter & Company) (Ad)tc pixel Free RVMDW Stock Alerts

Revolution Medicines (RVMDW) Competitors

Revolution Medicines logo
$11.41 -0.07 (-0.64%)
Closing price 08/11/2026 03:59 PM Eastern
Extended Trading
$11.45 +0.04 (+0.37%)
As of 08/11/2026 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

RVMDW vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy Revolution Medicines stock or one of its competitors? Revolution Medicines's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Revolution Medicines compare to Alvotech?

Revolution Medicines (NASDAQ:RVMDW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Revolution Medicines had 4 more articles in the media than Alvotech. MarketBeat recorded 6 mentions for Revolution Medicines and 2 mentions for Alvotech. Alvotech's average media sentiment score of 0.93 beat Revolution Medicines' score of 0.55 indicating that Alvotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revolution Medicines
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alvotech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Alvotech beats Revolution Medicines on 2 of the 3 factors compared between the two stocks.

How does Revolution Medicines compare to Apollomics?

Revolution Medicines (NASDAQ:RVMDW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
Apollomics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

In the previous week, Revolution Medicines had 3 more articles in the media than Apollomics. MarketBeat recorded 6 mentions for Revolution Medicines and 3 mentions for Apollomics. Revolution Medicines' average media sentiment score of 0.55 beat Apollomics' score of 0.29 indicating that Revolution Medicines is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revolution Medicines
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Apollomics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Revolution Medicines beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Revolution Medicines compare to Aravive?

Revolution Medicines (NASDAQ:RVMDW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, Revolution Medicines had 6 more articles in the media than Aravive. MarketBeat recorded 6 mentions for Revolution Medicines and 0 mentions for Aravive. Revolution Medicines' average media sentiment score of 0.55 beat Aravive's score of 0.00 indicating that Revolution Medicines is being referred to more favorably in the media.

Company Overall Sentiment
Revolution Medicines Positive
Aravive Neutral

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
Aravive N/A N/A N/A

Summary

Revolution Medicines and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does Revolution Medicines compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Revolution Medicines (NASDAQ:RVMDW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.61MN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Revolution Medicines N/A N/A N/A

In the previous week, Revolution Medicines had 4 more articles in the media than bioAffinity Technologies. MarketBeat recorded 6 mentions for Revolution Medicines and 2 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 0.97 beat Revolution Medicines' score of 0.55 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
bioAffinity Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Revolution Medicines
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

bioAffinity Technologies beats Revolution Medicines on 2 of the 3 factors compared between the two stocks.

How does Revolution Medicines compare to BioVie?

Revolution Medicines (NASDAQ:RVMDW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, Revolution Medicines had 5 more articles in the media than BioVie. MarketBeat recorded 6 mentions for Revolution Medicines and 1 mentions for BioVie. BioVie's average media sentiment score of 1.87 beat Revolution Medicines' score of 0.55 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
Revolution Medicines Positive
BioVie Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Revolution Medicines and BioVie tied by winning 1 of the 2 factors compared between the two stocks.

Get Revolution Medicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVMDW vs. The Competition

Export
MetricRevolution MedicinesBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.71B$7.08B$12.96B
Dividend YieldN/A3.76%2.57%10.34%
P/E RatioN/A10.37268.3925.05
Price / SalesN/A1,173.19559.5969.51
Price / CashN/A102.5472.2650.42
Price / BookN/A17.9713.216.18
Net IncomeN/A-$13.23M$3.44B$347.05M
7 Day Performance11.29%3.23%2.07%1.24%
1 Month Performance21.87%-1.13%-0.26%-0.65%
1 Year Performance5,329.32%59.41%70.30%20.12%

Revolution Medicines Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVMDW
Revolution Medicines
N/A$11.41
-0.6%		N/A+5,085.0%$0.00N/AN/A378
ALVOW
Alvotech
N/A$0.15
flat		N/A-88.7%$0.00$559.42MN/A4
APLMW
Apollomics
N/A$0.02
flat		N/A-29.0%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.07
+0.9%		N/A-37.5%$0.00$5.61MN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RVMDW) was last updated on 8/12/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken...
Freedom Financial | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
$8B is moving in... are you?
Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...
Awesomely | Sponsoredtc pixel
Bizarre price discrepancy in four tiny gold miners…
The four largest gold miners are generating record free cash flow, even with gold pulling back from recent hig...
Golden Portfolio | Sponsoredtc pixel